Decoding Bio

Thomas Miller is speaking at the AI x Bio Summit. Iambic is building the next generation of medicines using AI-driven molecular design. Tom will be in conversation with Chris Arendt (CSO, Takeda) on what AI-pharma partnership looks like from the inside. Tomorrow · New York Stock Exchange Apply to attend → https://lnkd.in/gfgmP-8Y

Benjamine Liu is joining us at the AI x Bio Summit. Formation Bio's thesis: the biggest bottleneck in drug development isn't discovery, it's the cost and time of clinical trials. They're using AI to change that. July 23 · New York Stock Exchange Apply to attend → https://lnkd.in/gfgmP-8Y

Marcus Schindler is coming to the AI x Bio Summit. As former Chief Scientific Officer of Novo Nordisk, he led the science behind one of pharma's most successful runs. He'll share what he learned about partnering with AI-first companies. July 23 · New York Stock Exchange Apply to attend → https://lnkd.in/gfgmP-8Y

Jorge Conde will be at the AI x Bio Summit. As a GP at Andreessen Horowitz focused on bio and health, he's had a front-row seat to how AI is reshaping what's worth building and what's worth funding in life sciences. July 23 · New York Stock Exchange Apply to attend → https://lnkd.in/gfgmP-8Y

AI x Bio Summit standard admission is officially sold out. The only way to join us on July 23rd at the NYSE is via a Reception-Only ticket. For $249, you'll have access to the evening reception alongside the speakers, founders, and investors who made the cut for this year's summit. Secure your spot here: https://lnkd.in/gttudhrr These are limited and once they're gone, they're gone.

Jason Kelly is coming to the AI x Bio Summit. As CEO of Ginkgo Bioworks, he's spent the last decade building the platform that programs cells the way engineers program software. Now AI is changing what that means. Join us July 23 at the New York Stock Exchange. Apply to attend → https://lnkd.in/gfgmP-8Y

Eli Berlin will be at the AI x Bio Summit. Terray Therapeutics built its own hardware, generated its own data, and trained its own AI, purpose-built to find drugs for the hardest targets, the ones with no chemistry starting point. July 23 · New York Stock Exchange Apply to attend → https://lnkd.in/gfgmP-8Y

Gleb Kuznetsov is joining us at the AI x Bio Summit. Manifold Bio built the first platform to design protein therapeutics and test millions of them directly in living systems, not just in a dish. The difference matters enormously for whether drugs actually work. July 23 · New York Stock Exchange Apply to attend → https://lnkd.in/gfgmP-8Y

Ron Alfa, MD, PhD is speaking at the AI x Bio Summit. NOETIK is using AI and high-throughput spatial data to decode tumor biology, building foundation models of cancer to find precision immunotherapies that actually work for the right patients. July 23 · New York Stock Exchange Apply to attend → https://lnkd.in/gfgmP-8Y

Sal Rais is joining us at the AI x Bio Summit. As Healthcare PM at T. Rowe Price, Salehin brings an investor's perspective on the companies shaping the future of AI and biotechnology, and what separates lasting innovation from hype. July 23 · NYSE Apply to attend → https://lnkd.in/gfgmP-8Y